ワッークッーちん！（ハヨ）ワッークっーちん（ハヨ）世界中からかき集めるべき

 ６５歳以上のワクチン接種、河野行革相「早くても４月１日」…「確定するのは供給次第

2021年1月27日7:43 午後2時間前更新 インド国産コロナワクチン、英国型変異種にも有効の可能性＝研究者 India Has Plenty of Coronavirus Vaccines But Few Takers By Bibhudatta Pradhan and Sudhi Ranjan Sen 2021年1月27日

As India rolls out one of the world’s biggest inoculation programs, some health-care and other frontline workers are hesitating because of safety concerns over a vaccine that has yet to complete phase III trials. As of Monday, only about 56% of people eligible to get the shot have stepped forward in a nation with the world’s second-worst Covid-19 outbreak.

“At least 40% of doctors here are unsure and want to wait,” said Vinod Kumar, a resident doctor at the All India Institute of Medical Sciences of Patna, in the eastern state of Bihar.

“Covaxin could turn out to be a better vaccine in the future,” said Mohapatra, who is also vice president of the resident doctors’ association at the hospital. “But for now there is some apprehension because of the lack of a complete trial.

はああああ・・・・（ため息）。インドは供給力あるんだけど、安全生がまだ確認できてないのかああ。 

India says it can produce 500 million shots per month for export, and countries such as the U.K., Belgium and Saudi Arabia have sought to buy them

ただ、UKやベルギーサウジアラビアから需要もある、と。 

”